Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07VIO
|
||||
| Former ID |
DNC014310
|
||||
| Drug Name |
3-(2-Diethylamino-acetamino)-rutaecarpine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530639] | ||
| Formula |
C24H25N5O2
|
||||
| Canonical SMILES |
CCN(CC)CC(=O)NC1=CC2=C(C=C1)N=C3C4=C(CCN3C2=O)C5=CC=CC=<br />C5N4
|
||||
| InChI |
1S/C24H25N5O2/c1-3-28(4-2)14-21(30)25-15-9-10-20-18(13-15)24(31)29-12-11-17-16-7-5-6-8-19(16)26-22(17)23(29)27-20/h5-10,13,26H,3-4,11-12,14H2,1-2H3,(H,25,30)
|
||||
| InChIKey |
IIFLCYXLKCVJJT-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cholinesterase | Target Info | Inhibitor | [530639] | |
| Acetylcholinesterase | Target Info | Inhibitor | [530639] | ||
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Cholinergic synapse | |||||
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| Pathway Interaction Database | ATF-2 transcription factor network | ||||
| PathWhiz Pathway | Phospholipid Biosynthesis | ||||
| References | |||||